Bionime Bilan de santé
Santé financière contrôle des critères 1/6
Bionime has a total shareholder equity of NT$1.9B and total debt of NT$2.8B, which brings its debt-to-equity ratio to 148%. Its total assets and total liabilities are NT$5.4B and NT$3.5B respectively.
Informations clés
148.0%
Ratio d'endettement
NT$2.81b
Dette
Ratio de couverture des intérêts | n/a |
Argent liquide | NT$321.43m |
Fonds propres | NT$1.90b |
Total du passif | NT$3.53b |
Total des actifs | NT$5.42b |
Mises à jour récentes de la santé financière
Recent updates
Bionime (TWSE:4737) Is Reducing Its Dividend To NT$2
Jul 22Bionime (TWSE:4737) Will Pay A Smaller Dividend Than Last Year
Jul 01These Return Metrics Don't Make Bionime (TPE:4737) Look Too Strong
Apr 29Looking For Steady Income For Your Dividend Portfolio? Is Bionime Corporation (TPE:4737) A Good Fit?
Mar 23Did You Participate In Any Of Bionime's (TPE:4737) Respectable 83% Return?
Mar 05Should You Use Bionime's (TPE:4737) Statutory Earnings To Analyse It?
Feb 15Bionime (TPE:4737) Has A Somewhat Strained Balance Sheet
Feb 01How Has Bionime (TPE:4737) Allocated Its Capital?
Jan 19A Closer Look At Bionime Corporation's (TPE:4737) Uninspiring ROE
Jan 06A Look At The Fair Value Of Bionime Corporation (TPE:4737)
Dec 22Bionime Corporation (TPE:4737) Investors Should Think About This Before Buying It For Its Dividend
Dec 09Bionime (TPE:4737) Has Compensated Shareholders With A Respectable 50% Return On Their Investment
Nov 24Analyse de la situation financière
Passif à court terme: 4737's short term assets (NT$1.6B) do not cover its short term liabilities (NT$2.1B).
Passif à long terme: 4737's short term assets (NT$1.6B) exceed its long term liabilities (NT$1.4B).
Historique et analyse du ratio d'endettement
Niveau d'endettement: 4737's net debt to equity ratio (131.1%) is considered high.
Réduire la dette: 4737's debt to equity ratio has increased from 94.5% to 148% over the past 5 years.
Couverture de la dette: 4737's debt is not well covered by operating cash flow (3.6%).
Couverture des intérêts: Insufficient data to determine if 4737's interest payments on its debt are well covered by EBIT.